Autres langues LivaNova PLC

Actions

LIVN

GB00BYMT0J19

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 13/05/2024			Varia. 5j.	Varia. 1 janv.
61,14 ^USD	-1,55 %		-2,33 %	+18,17 %

01/05	LivaNova augmente ses bénéfices ajustés et son chiffre d'affaires au 1er trimestre, dépassant les prévisions de Street View ; elle relève ses prévisions pour 2024	MT
01/05	Transcript : LivaNova PLC, Q1 2024 Earnings Call, May 01, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

LivaNova : 1Q 2024 Earnings Press Release	02/05
LivaNova's Q1 Adjusted Earnings, Revenue Rise, Tops Street View; Raises 2024 Guidance	01/05
Earnings Flash (LIVN) LIVANOVA Reports Q1 Revenue $294.9M, vs. Street Est of $278.2M	01/05
Earnings Flash (LIVN) LIVANOVA Posts Q1 EPS $0.73, vs. Street Est of $0.49	01/05
LivaNova: Q1 Earnings Snapshot	01/05
LivaNova Reports First-Quarter 2024 Results	01/05
LivaNova PLC Provides Earnings Guidance for the Full-Year 2024	01/05
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	01/05
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	30/04
LivaNova PLC Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer	30/04
LivaNova : 2023 UK Annual Report	26/04
LivaNova : 2024 Proxy Statement and Notice of Annual General Meeting	26/04
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident	25/04
LivaNova to Announce First-Quarter 2024 Results	21/03
Sector Update: Health Care Stocks Ease Late Afternoon	20/03
Sector Update: Health Care Stocks Down Wednesday Afternoon	20/03
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	20/03
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	20/03
LivaNova PLC Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	20/03
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues LivaNova PLC

Actions

LIVN

GB00BYMT0J19

Autres langues

Filtres